These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Treated by Yttrium-90 Resin Microsphere Radioembolization: A Retrospective Analysis Using Technetium-99m Macroaggregated Albumin SPECT/CT and Planning Software. Doyle PW; Workman CS; Grice JV; McGonigle TW; Huang S; Borgmann AJ; Baker JC; Duncan DP; Taylor JE; Brown DB J Vasc Interv Radiol; 2024 May; 35(5):689-698.e3. PubMed ID: 38246416 [TBL] [Abstract][Full Text] [Related]
23. 90Y PET-based dosimetry after selective internal radiotherapy treatments. D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156 [TBL] [Abstract][Full Text] [Related]
24. Planning dosimetry for Thomas MA; Mahvash A; Abdelsalam M; Kaseb AO; Kappadath SC Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882 [TBL] [Abstract][Full Text] [Related]
25. PET-CT post therapy dosimetry in radioembolization with resin Richetta E; Pasquino M; Poli M; Cutaia C; Valero C; Tabone M; Paradisi BP; Pacilio M; Pellerito RE; Stasi M Phys Med; 2019 Aug; 64():16-23. PubMed ID: 31515015 [TBL] [Abstract][Full Text] [Related]
26. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387 [TBL] [Abstract][Full Text] [Related]
28. Radioembolization of hepatocarcinoma with Chiesa C; Mira M; Bhoori S; Bormolini G; Maccauro M; Spreafico C; Cascella T; Cavallo A; De Nile MC; Mazzaglia S; Capozza A; Tagliabue G; Brusa A; Marchianò A; Seregni E; Mazzaferro V Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3018-3032. PubMed ID: 32451604 [TBL] [Abstract][Full Text] [Related]
29. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V; Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828 [TBL] [Abstract][Full Text] [Related]
30. Metabolic activity assessment by Kim DY; Lee HW; Kang W; Kim GM; Won JY; Yun M J Gastroenterol Hepatol; 2021 Jun; 36(6):1679-1684. PubMed ID: 33226706 [TBL] [Abstract][Full Text] [Related]
31. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing Noipinit N; Sukprakun C; Siricharoen P; Khamwan K Ann Nucl Med; 2024 Mar; 38(3):210-218. PubMed ID: 38142421 [TBL] [Abstract][Full Text] [Related]
32. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases. Kousik V; Promila P; Verma R; Gupta A Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180 [TBL] [Abstract][Full Text] [Related]
33. Comparison of perfused volume segmentation between cone-beam CT and Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960 [TBL] [Abstract][Full Text] [Related]
34. Intraprocedural C-arm dual-phase cone-beam enhancement patterns correlate with tumor absorbed dose after radioembolization. Bastiaannet R; Lin M; Frey EC; de Jong HWAM Med Phys; 2024 Apr; 51(4):3045-3052. PubMed ID: 38064591 [TBL] [Abstract][Full Text] [Related]
37. Retrospective SPECT/CT dosimetry following transarterial radioembolization. Thompson BC; Dezarn WA J Appl Clin Med Phys; 2021 Apr; 22(4):143-150. PubMed ID: 33710776 [TBL] [Abstract][Full Text] [Related]
38. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma. Syed M; Shah J; Montazeri SA; Grajo JR; Geller B; Toskich B Abdom Radiol (NY); 2021 May; 46(5):2182-2187. PubMed ID: 33216180 [TBL] [Abstract][Full Text] [Related]
39. A deep-learning-based prediction model for the biodistribution of Plachouris D; Tzolas I; Gatos I; Papadimitroulas P; Spyridonidis T; Apostolopoulos D; Papathanasiou N; Visvikis D; Plachouri KM; Hazle JD; Kagadis GC Med Phys; 2021 Nov; 48(11):7427-7438. PubMed ID: 34628667 [TBL] [Abstract][Full Text] [Related]
40. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise Roosen J; van Wijk MWM; Westlund Gotby LEL; Arntz MJ; Janssen MJR; Lobeek D; van de Maat GH; Overduin CG; Nijsen JFW Med Phys; 2023 Feb; 50(2):935-946. PubMed ID: 36202392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]